Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma (vol 24, pg 289, 2013)

Leung-Hagesteijn Chungyee; Erdmann Natalie; Cheung Grace; Keats Jonathan J.; Stewart A. Keith; Reece Donna E.; Chung Kim Chan; Tiedemann Rodger E.

首页> 外文期刊>Cancer Cell >Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma (vol 24, pg 289, 2013)

【24h】

Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma (vol 24, pg 289, 2013)

机译：XBP1S阴性肿瘤B细胞和预浆浆料介导多发性骨髓瘤治疗蛋白酶体抑制剂（Vol 24，PG 289,2013）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer Cell》 |2015年第4期|共2页
作者
Leung-Hagesteijn Chungyee; Erdmann Natalie; Cheung Grace; Keats Jonathan J.; Stewart A. Keith; Reece Donna E.; Chung Kim Chan; Tiedemann Rodger E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma (vol 24, pg 289, 2013) [J] . Leung-Hagesteijn Chungyee, Erdmann Natalie, Cheung Grace, Cancer Cell . 2015,第4期

机译：Xbp1s阴性肿瘤B细胞和成前成骨细胞介导多发性骨髓瘤的治疗性蛋白酶体抑制剂抗性（第24卷，第289页，2013年）
2. Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma [J] . Leung-HagesteijnC., ErdmannN., CheungG., Cancer Cell . 2013,第3期

机译：Xbp1s阴性肿瘤B细胞和成前成骨细胞介导多发性骨髓瘤的治疗蛋白酶体抑制剂抗性。
3. Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance [J] . Muz Barbara, Kusdono Hubert D., Azab Feda, Leukemia and lymphoma . 2017,第11a12期

机译：Tariquidar通过降低缺氧诱导的p-GP介导的耐药性致敏抗蛋白酶体抑制剂对蛋白酶体抑制剂的多种骨髓瘤细胞敏感
4. Novel Therapeutics for Inhibiting Tumor Epithelial-Mesenchymal Transition (EMT), a Key Driver of Metastasis and a Mechanism of Drug-Resistance [C] . Sergej M. Kiprijanov, Gro Gausdal, Tone Sal, PEGS . 2014

机译：抑制肿瘤上皮 - 间充质转换（EMT），转移的关键驱动器和抗药性机制的新型治疗剂
5. The Role of Klf9 in Cell Stress-Induced Cell Death In Normal Cells and in the Therapeutic Response of Multiple Myeloma Cells to Proteasome Inhibitors [D] . Fink, Emily 2017

机译：Klf9在正常细胞中细胞应激诱导的细胞死亡中的作用以及在多发性骨髓瘤细胞对蛋白酶体抑制剂的治疗反应中的作用
6. Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma [O] . Chungyee Leung-Hagesteijn, Natalie Erdmann, Grace Cheung, -1

机译：Xbp1s阴性肿瘤B细胞和成前成骨细胞介导多发性骨髓瘤的治疗性蛋白酶体抑制剂抗性。
7. Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma [O] . Leung-Hagesteijn Chungyee, Erdmann Natalie, Cheung Grace, 2015

机译：Xbp1s阴性肿瘤B细胞和成前成骨细胞介导多发性骨髓瘤的治疗性蛋白酶体抑制剂抗性。

Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma (vol 24, pg 289, 2013)

著录项

相似文献

相关主题

期刊订阅